RobertSGoldmanMD

PubMed

• 17 citations
  Efficacy and safety of dasotraline in adults with binge-eating disorder: a randomized, placebo-controlled, fixed-dose clinical trial.
  Carlos M. Grilo, Susan L. McElroy, James I. Hudson, Joyce Tsai, Bradford Navia, Robert Goldman, Ling Deng, Justine Kent, Antony Loebel> ;CNS Spectrums. 2021 Oct 1
• 3 citations
  Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression.
  Melissa P. DelBello, Michael Tocco, Andrei Pikalov, Ling Deng, Robert Goldman> ;Journal of Child and Adolescent Psychopharmacology. 2021 Jul 29
• 7 citations
  Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: A pooled post hoc analysis of double-blind, placebo-controlled 6-week studies
  Isabella Costamagna, Fabrizio Calisti, Agnese Cattaneo, Jay Hsu, Michael Tocco, Andrei Pikalov, Robert Goldman> ;European Psychiatry. 2021 May 10
• Dasotraline in adults with attention deficit hyperactivity disorder: a placebo-controlled, fixed-dose trial.
  Lenard A. Adler, Robert Goldman, Seth C. Hopkins, Kenneth S. Koblan, Justine Kent, Jay Hsu, Antony Loebel> ;International Clinical Psychopharmacology. 2021 Mar 12
• 14 citations
  Efficacy and Safety of Dasotraline in Adults With Binge-Eating Disorder: A Randomized, Placebo-Controlled, Flexible-Dose Clinical Trial.
  Susan L. McElroy, James I. Hudson, Carlos M. Grilo, Anna I. Guerdjikova, Ling Deng, Kenneth S. Koblan, Robert Goldman, Bradford Navia, Seth C. Hopkins, and Antony Loebel> ;The Journal of Clinical Psychiatry. 2020 Sep 8
• 145 citations
  A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia
  Kenneth S. Koblan, Justine Kent, Seth C. Hopkins, John H. Krystal, Hailong Cheng, Robert Goldman, Antony Loebel> ;The New England Journal of Medicine. 2020 Apr 15
• 159 Safety and Efficacy of Lurasidone in Children and Adolescents with Bipolar Depression: Results from a 2-Year Open-label Extension Study
  Melissa P. DelBello, Robert S. Goldman, Michael Tocco, Ling Deng, Andrei Pikalov> ;Cns Spectrums. 2020 Apr 1
• 12 citations
  Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study.
  Sharon B. Wigal, Seth C. Hopkins, Kenneth S. Koblan, Ann C. Childress, Justine Kent, Joyce Tsai, Jay Hsu, Antony Loebel, Robert Goldman> ;Journal of Attention Disorders. 2020 Jan 1
• 20 citations
  Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial
  Robert L. Findling, Lenard A. Adler, Thomas J. Spencer, Robert Goldman, Seth C. Hopkins, Kenneth S. Koblan, Justine Kent, Jay Hsu, Antony Loebel> ;Journal of Child and Adolescent Psychopharmacology. 2019 Mar 7
• Clinical Relevance Versus Statistical Significance: DelBello and Colleagues Respond to Editorial.
  Melissa P. DelBello, Robert Goldman, Antony Loebel> ;Journal of the American Academy of Child and Adolescent Psychiatry. 2018 May 1
• 52 citations
  Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study
  Melissa P. DelBello, Robert Goldman, Debra Phillips, Ling Deng, Josephine Cucchiaro, Antony Loebel> ;Journal of the American Academy of Child and Adolescent Psychiatry. 2017 Dec 1
• 24 citations
  Efficacy and Safety of Lurasidone in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study
  Robert Goldman, Antony Loebel, Josephine Cucchiaro, Ling Deng, Robert L. Findling> ;Journal of Child and Adolescent Psychopharmacology. 2017 Aug 1
• 22 citations
  Lurasidone Dose Escalation in Early Nonresponding Patients With Schizophrenia: A Randomized, Placebo-Controlled Study
  Antony Loebel, Robert Silva, Robert Goldman, Kei Watabe, Josephine Cucchiaro, Leslie Citrome, John M. Kane> ;The Journal of Clinical Psychiatry. 2016 Dec 28
• 48 citations
  Lurasidone for the Treatment of Irritability Associated with Autistic Disorder
  Antony Loebel, Matthew Brams, Robert Goldman, Robert Silva, David Hernandez, Ling Deng, Raymond Mankoski, Robert L. Findling> ;Journal of Autism and Developmental Disorders. 2016 Apr 1
• 27 citations
  Pharmacokinetics and Tolerability of Lurasidone in Children and Adolescents With Psychiatric Disorders
  Robert L. Findling, Robert Goldman, Yu Yuan Chiu, Robert Silva, F. Jin, Andrei Pikalov, Antony Loebel> ;Clinical Therapeutics. 2015 Dec 1
• 38 citations
  Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults
  Kenneth S. Koblan, Seth C. Hopkins, Kaushik Sarma, F. Jin, Robert Goldman, Scott H. Kollins, Antony Loebel> ;Neuropsychopharmacology. 2015 May 7
• 19 citations
  An MRI substudy of a donepezil clinical trial in mild cognitive impairment
  Norbert Schuff, Joyce Suhy, Robert Goldman, Yikang Xu, Yijun Sun, Diana Truran-Sacrey, Anita Murthy> ;Neurobiology of Aging. 2011 Dec 1
• 5 citations
  Identifying amnestic mild cognitive impairment in primary care: a feasibility study.
  Rachelle S. Doody, Steven H. Ferris, Stephen Salloway, Thomas M. Meuser, Anita Murthy, Chunming Li, Robert Goldman> ;Clinical Drug Investigation. 2011 Jan 1
• 81 citations
  Circumstances Under Which Practice Does Not Make Perfect: A Review of the Practice Effect Literature in Schizophrenia and Its Relevance to Clinical Treatment Studies
  Terry E. Goldberg, Richard S.E. Keefe, Robert Goldman, Delbert Robinson, Philip D Harvey> ;Neuropsychopharmacology. 2010 Jan 20
• 10 citations
  Safety and Tolerability of Donepezil in Mild Cognitive Impairment: Open-Label Extension Study
  Rachelle S. Doody, Steven H. Ferris, Stephen Salloway, Yijun Sun, Robert Goldman, Yikang Xu, Jeff Gao, Anita Murthy> ;American Journal of Alzheimer's Disease and Other Dementias. 2010 Mar 1
• 11 citations
  Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
  R S Doody, S H Ferris, S Salloway, Y Sun, R Goldman, W E Watkins, Y Xu, A K Murthy> ;Neurology. 2009 May 5
• 44 citations
  Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia
  Terry E. Goldberg, Katherine E. Burdick, Joanne McCormack, Barbara Napolitano, Raman C. Patel, Serge Sevy, Robert Goldman, Todd Lencz, Anil K. Malhotra, John M. Kane, ...> ;Schizophrenia Research. 2009 Feb 1
• 103 citations
  Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blin...
  Richard S.E. Keefe, Anil K. Malhotra, Herbert Y. Meltzer, John M. Kane, Robert W. Buchanan, Anita Murthy, Mindy Sovel, Chunming Li, Robert Goldman> ;Neuropsychopharmacology. 2008 May 1
• 9 citations
  Self-reported cognitive and everyday functioning in persons with psychosis : the Patient Perception of Functioning Scale
  Thomas S. Ehmann, Robert Goldman, Jodi Yager, Yikang Xu, G.W. MacEwan> ;Comprehensive Psychiatry. 2007 Nov 1
• 302 citations
  Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
  Terry E. Goldberg, Robert Goldman, Katherine E. Burdick, Anil K. Malhotra, Todd Lencz, Raman C. Patel, Woerner M, Nina R. Schooler, John M. Kane, Delbert G. Robinson> ;Archives of General Psychiatry. 2007 Oct 1
• Join now to see all